Cristina Di Giorgio - Concepedia

Author

Cristina Di Giorgio

University of Naples Federico II ORCID

Also Known As

C Giorgio, Cristina Di Giorgio, Cristina Giorgio, Cristina di Giorgio

Publications

981

Citations

H-Index

Concepts

All Affiliations

University of Naples Federico II University of Perugia Azienda Ospedaliera di Perugia University of Salerno Magna Graecia University

About

Cristina Di Giorgio is an author at University of Naples Federico II specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	154
2	Health Sciences	3	3	92
3	Biochemistry	3	3	82
4	Cell Biology	2	2	32
5	Hepatology	2	2	66

Cristina Di Giorgio

Publications

635

Citations

H-Index

Page 1

	Year	Citations
miR-194-5p/BCLAF1 deregulation in AML tumorigenesis Carmela Dell’Aversana, Cristina Di Giorgio, Leo D’Amato, Leukemia	2017	85
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis Michele Biagioli, Adriana Carino, Chiara Fiorucci, Cellular and Molecular Gastroenterology and Hepatology	2019	62
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity Michele Biagioli, Adriana Carino, Chiara Fiorucci, The Journal of Immunology	2020	50
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis Adriana Carino, Michele Biagioli, Silvia Marchianò, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids Opposite EffectsHepatologyBiochemistryMedicineLiver Physiology	2020	40
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation Adriana Carino, Silvia Marchianò, Michele Biagioli, Nutrients	2019	32
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction Michele Biagioli, Silvia Marchianò, Rosalinda Roselli, Biochemical Pharmacology Molecular PharmacologyAce2-sars-cov-2 InteractionSignal TransductionMedicineImmunology	2021	30
The Aryl Hydrocarbon Receptor (AhR) Mediates the Counter-Regulatory Effects of Pelargonidins in Models of Inflammation and Metabolic Dysfunctions Michele Biagioli, Adriana Carino, Chiara Fiorucci, Nutrients	2019	28
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling Silvia Marchianò, Michele Biagioli, Rosalinda Roselli, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids InflammationMetabolic SyndromeSignal TransductionOxysterolBeneficial Effects	2022	26
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH Silvia Marchianò, Michele Biagioli, Elva Morretta, Scientific Reports ImmunologyPathologyFatty Liver DiseaseBile Acid ContentMetabolic Syndrome	2023	26
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy Adriana Carino, Silvia Marchianò, Michele Biagioli, The FASEB Journal	2020	23

Page 1